Trinity Biotech | TRIB - Operating Expenses


Trinity Biotech reported $12.38M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 10.46B 1.15B Jun/2026
Bayer EUR 10.04B 168M Jun/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
EDAP TMS EUR 25.18M 6.37M Mar/2026
J&J USD 17.83B 388M Jun/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Siemens EUR 17.6B 531M Jun/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Tosoh JPY 242.99B 4.79B Jun/2026
Trinity Biotech USD 12.38M 2.44M Dec/2025
Veracyte USD 126.36M 6.37M Jun/2026